Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial update on the efficacy and safety of the Sofosbuvir/Velpatasvir fixed-dose combination for chronic hepatitis C virus infection has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-07-17